PMC:7558233 / 28688-28915 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"757","span":{"begin":186,"end":194},"obj":"Species"},{"id":"787","span":{"begin":14,"end":29},"obj":"Disease"},{"id":"788","span":{"begin":47,"end":53},"obj":"Disease"},{"id":"789","span":{"begin":106,"end":114},"obj":"Disease"},{"id":"790","span":{"begin":210,"end":226},"obj":"Disease"}],"attributes":[{"id":"A757","pred":"tao:has_database_id","subj":"757","obj":"Tax:9606"},{"id":"A787","pred":"tao:has_database_id","subj":"787","obj":"MESH:D001102"},{"id":"A788","pred":"tao:has_database_id","subj":"788","obj":"MESH:D018805"},{"id":"A789","pred":"tao:has_database_id","subj":"789","obj":"MESH:C000657245"},{"id":"A790","pred":"tao:has_database_id","subj":"790","obj":"MESH:D016638"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The fact that viral infection (including viral sepsis) [79] remains the key driver of the pathogenesis of COVID-19 has fueled research exploring the efficacy of antiviral medications in patients with severe or critical illness."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T52","span":{"begin":47,"end":53},"obj":"Phenotype"}],"attributes":[{"id":"A52","pred":"hp_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/HP_0100806"}],"text":"The fact that viral infection (including viral sepsis) [79] remains the key driver of the pathogenesis of COVID-19 has fueled research exploring the efficacy of antiviral medications in patients with severe or critical illness."}

{"project":"LitCovid-sentences","denotations":[{"id":"T174","span":{"begin":0,"end":227},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The fact that viral infection (including viral sepsis) [79] remains the key driver of the pathogenesis of COVID-19 has fueled research exploring the efficacy of antiviral medications in patients with severe or critical illness."}

{"project":"MyTest","denotations":[{"id":"33078078-32311318-28132408","span":{"begin":56,"end":58},"obj":"32311318"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"The fact that viral infection (including viral sepsis) [79] remains the key driver of the pathogenesis of COVID-19 has fueled research exploring the efficacy of antiviral medications in patients with severe or critical illness."}

{"project":"2_test","denotations":[{"id":"33078078-32311318-28132408","span":{"begin":56,"end":58},"obj":"32311318"}],"text":"The fact that viral infection (including viral sepsis) [79] remains the key driver of the pathogenesis of COVID-19 has fueled research exploring the efficacy of antiviral medications in patients with severe or critical illness."}